Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal
https://economictimes.indiatimes.com/markets/stocks/news/gland-pharma-shares-promoter-fosun-pharma-likely-to-divest-5-equity-worth-rs-2279-crore-via-block-deal/articleshow/133740560.cms
Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a 47% rise in Q1FY27 profit and operates globally, with strong R&D and growth.
September 3, 2026 9
